Cumberland Pharmaceuticals Inc. Deferred Income Tax Expense (Benefit)
Cumberland Pharmaceuticals Inc. (CPIX) reported Deferred Income Tax Expense (Benefit) of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2023-03-13
- Cumberland Pharmaceuticals Inc. deferred income tax expense (benefit) for the quarter ending 2020-12-31 was $21.80K, a 0.00% decline year-over-year.
- Cumberland Pharmaceuticals Inc. deferred income tax expense (benefit) for the quarter ending 2020-09-30 was $0.00.
- Cumberland Pharmaceuticals Inc. deferred income tax expense (benefit) for the quarter ending 2020-06-30 was $0.00.
- Cumberland Pharmaceuticals Inc. deferred income tax expense (benefit) for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- Cumberland Pharmaceuticals Inc. deferred income tax expense (benefit) for fiscal 2022 was $0.00.
- Cumberland Pharmaceuticals Inc. deferred income tax expense (benefit) for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Cumberland Pharmaceuticals Inc. deferred income tax expense (benefit) for fiscal 2020 was $21.80K, a 66.67% decline from fiscal 2019.
- Cumberland Pharmaceuticals Inc. deferred income tax expense (benefit) for fiscal 2019 was $65.41K, a 20.12% decline from fiscal 2018.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-13 | |||
| 2021-12-31 | $0.00 10-K · filed 2023-03-13 | |||
| 2020-12-31 | $21.80K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $21.80K derived: sum of 2 quarters · filed 2022-03-11 | $21.80K derived: sum of 3 quarters · filed 2022-03-11 | $21.80K 10-K · filed 2022-03-11 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $0.00 10-Q · filed 2020-11-13 | $21.80K derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $0.00 10-Q · filed 2020-08-14 | $21.80K derived: sum of 3 quarters · filed 2022-03-11 | $21.80K derived: sum of 4 quarters · filed 2022-03-11 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-22 | $21.80K derived: sum of 2 quarters · filed 2022-03-11 | $21.80K derived: sum of 3 quarters · filed 2022-03-11 | $21.80K derived: sum of 4 quarters · filed 2022-03-11 |
| 2019-12-31 | $21.80K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $21.80K derived: sum of 2 quarters · filed 2022-03-11 | $21.80K derived: sum of 3 quarters · filed 2022-03-11 | $65.41K 10-K · filed 2022-03-11 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $43.60K 10-Q · filed 2020-11-13 | $125.49K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $43.60K 10-Q · filed 2020-08-14 | $125.49K derived: sum of 3 quarters · filed 2021-03-12 | $125.49K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $43.60K 10-Q · filed 2020-05-22 | $125.49K derived: sum of 2 quarters · filed 2021-03-12 | $125.49K derived: sum of 3 quarters · filed 2021-03-12 | $125.49K derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $81.89K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $81.89K derived: sum of 2 quarters · filed 2021-03-12 | $81.89K derived: sum of 3 quarters · filed 2021-03-12 | $81.89K 10-K · filed 2021-03-12 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $0.00 derived: sum of 2 quarters · filed 2019-11-13 | $0.00 10-Q · filed 2019-11-13 | -$87.21K derived: sum of 4 quarters · filed 2020-12-10 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | -$87.21K derived: sum of 3 quarters · filed 2020-12-10 | -$87.21K derived: sum of 4 quarters · filed 2020-12-10 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-15 | -$87.21K derived: sum of 2 quarters · filed 2020-12-10 | -$87.21K derived: sum of 3 quarters · filed 2020-12-10 | $3.45M derived: sum of 4 quarters · filed 2020-12-10 |
| 2017-12-31 | -$87.21K derived: 8-K 12 month − 10-Q 9 month · filed 2020-12-10 | -$87.21K derived: sum of 2 quarters · filed 2020-12-10 | $3.45M derived: sum of 3 quarters · filed 2020-12-10 | $4.21M 8-K · filed 2020-12-10 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $3.54M derived: sum of 2 quarters · filed 2018-11-14 | $4.29M 10-Q · filed 2018-11-14 | $4.25M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | $3.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $4.29M 10-Q · filed 2018-08-14 | $4.25M derived: sum of 3 quarters · filed 2019-03-12 | $4.38M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | $758.11K 10-Q · filed 2018-05-09 | $715.00K derived: sum of 2 quarters · filed 2019-03-12 | $844.63K derived: sum of 3 quarters · filed 2019-03-12 | $1.17M derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | -$43.11K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $86.51K derived: sum of 2 quarters · filed 2019-03-12 | $415.51K derived: sum of 3 quarters · filed 2019-03-12 | $619.58K 10-K · filed 2019-03-12 |
| 2016-09-30 | $129.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $458.62K derived: sum of 2 quarters · filed 2017-11-08 | $662.69K 10-Q · filed 2017-11-08 | $1.11M derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-06-30 | $329.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $533.07K 10-Q · filed 2017-08-09 | $979.30K derived: sum of 3 quarters · filed 2018-03-09 | $999.70K derived: sum of 4 quarters · filed 2018-03-09 |
| 2016-03-31 | $204.07K 10-Q · filed 2017-05-15 | $650.30K derived: sum of 2 quarters · filed 2018-03-09 | $670.70K derived: sum of 3 quarters · filed 2018-03-09 | $694.29K derived: sum of 4 quarters · filed 2018-03-09 |
| 2015-12-31 | $446.24K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $466.63K derived: sum of 2 quarters · filed 2018-03-09 | $490.23K derived: sum of 3 quarters · filed 2018-03-09 | $490.23K 10-K · filed 2018-03-09 |
| 2015-09-30 | $20.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $43.99K derived: sum of 2 quarters · filed 2016-11-03 | $43.99K 10-Q · filed 2016-11-03 | -$229.08K derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | $23.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $23.59K 10-Q · filed 2016-08-05 | -$249.48K derived: sum of 3 quarters · filed 2017-03-13 | -$285.74K derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | $0.00 10-Q · filed 2016-05-13 | -$273.07K derived: sum of 2 quarters · filed 2017-03-13 | -$309.33K derived: sum of 3 quarters · filed 2017-03-13 | -$309.33K derived: sum of 4 quarters · filed 2017-03-13 |
| 2014-12-31 | -$273.07K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | -$309.33K derived: sum of 2 quarters · filed 2017-03-13 | -$309.33K derived: sum of 3 quarters · filed 2017-03-13 | -$309.33K 10-K · filed 2017-03-13 |
| 2014-09-30 | -$36.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$36.26K derived: sum of 2 quarters · filed 2015-11-06 | -$36.26K 10-Q · filed 2015-11-06 | -$1.54M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $0.00 10-Q · filed 2015-08-07 | -$1.50M derived: sum of 3 quarters · filed 2016-03-14 | -$1.65M derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | -$1.50M derived: sum of 2 quarters · filed 2016-03-14 | -$1.65M derived: sum of 3 quarters · filed 2016-03-14 | -$1.65M derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$1.65M derived: sum of 2 quarters · filed 2016-03-14 | -$1.65M derived: sum of 3 quarters · filed 2016-03-14 | -$1.58M 10-K · filed 2016-03-14 |
| 2013-09-30 | -$141.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$141.75K derived: sum of 2 quarters · filed 2014-11-07 | -$76.33K 10-Q · filed 2014-11-07 | -$906.18K derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $65.41K 10-Q · filed 2014-08-08 | -$764.43K derived: sum of 3 quarters · filed 2015-03-09 | -$764.43K derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-03-31 | $65.41K 10-Q · filed 2014-05-12 | -$764.43K derived: sum of 2 quarters · filed 2015-03-09 | -$764.43K derived: sum of 3 quarters · filed 2015-03-09 | -$764.43K derived: sum of 4 quarters · filed 2015-03-09 |
| 2012-12-31 | -$829.85K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | -$829.85K derived: sum of 2 quarters · filed 2015-03-09 | -$829.85K derived: sum of 3 quarters · filed 2015-03-09 | -$829.85K 10-K · filed 2015-03-09 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $0.00 derived: sum of 2 quarters · filed 2013-11-06 | $0.00 10-Q · filed 2013-11-06 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | $1.67M 10-K · filed 2014-03-11 | |||
| 2010-12-31 | -$332.35K 10-K · filed 2013-03-12 | |||
| 2009-12-31 | -$525.47K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |